Ruofei Du
Associate Professor
Also affiliated: Rutgers, The State University of New Jersey (2016); Northwestern University (2014); University of North Carolina at Chapel Hill (2016); University of Arizona (2014–2015); University of New Mexico (2016–2024); Georgetown University (2016); University of Utah (2016); New Mexico Cancer Center (2020); BDM International (United States) (2018); UNM Comprehensive Cancer Center (2016–2024); University of New Mexico Health Sciences Center (2017–2024); Louisiana State University Health Sciences Center New Orleans (2012–2014)
Biostatistics, College of Public Health
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Ruofei Du is an Associate Professor in Biostatistics at the University of Arkansas for Medical Sciences. Her research interests include analyzing population-based incidence rates of diseases such as cervical intraepithelial neoplasia, particularly within the context of the human papillomavirus vaccine era. She has also investigated the efficacy of different methods for delivering genetic counseling, comparing telephone-based interventions to in-person approaches. Du's work extends to the development of robust statistical methods for identifying differential abundance in metagenomic samples and exploring the structural implications of human microRNA molecules. Her recent publications also address interventions for older cancer survivors, examining metal exposure and oxidative stress markers in pregnant individuals, and analyzing the prognostic value of thyroid hormones in acute ischemic stroke. She has a published h-index of 16 with 55 total publications and 838 citations.
Metrics
- h-index: 16
- Publications: 45
- Citations: 826
Positions
-
Associate Professor publications 2021–2026University of Arkansas for Medical Sciences Biostatistics, College of Public Health Institutional directory
Selected Publications
-
Is there an association between folic acid food fortification and the risk of COVID-19 incidence or mortality? (2026)
-
A data-driven single substitution to overcome bias from conventional single substitution for LOD missingness in covariates in least squares regression (2026)
-
Implementation of an Order Set Prior to Delivery Discharge for Postpartum Glucose Testing in Gestational Diabetes: Gaps in Follow-up and Opportunities for Improvement (2026)
-
Use of Nitrous Oxide during Labor in an Academic Medical Center in a Rural State (2026)
-
Associations of racialized economic segregation with the prevalence of unhealthy behaviors and poor mental health in the United States (2026)
-
Risk Factors for a Primary Cesarean Delivery in Pregnancies Complicated by Pregestational Diabetes (2026)
-
Contributing Factors to Delay of Adjuvant Postsurgical Radiation for Malignant Brain Tumors (2025)
-
Implementation of an Order Set Prior to Delivery Discharge for Postpartum Glucose Testing in Gestational Diabetes: Gaps in Follow-Up and Opportunities for Improvement (2025)
-
Geranylgeranyl Transferase Inhibitors Mitigate Intestinal Radiation Toxicity (2025)
-
Capacity to address determinants of health among a social justice coalition in the United States (2025)
-
Sex-specific immune alterations in mice following long-term simulated microgravity and chronic irradiation (2025)
-
Perinatal Outcomes and Management of Umbilical Vein Varix: A Comprehensive Review of 392 Cases (2025)
-
Caregiver restrictions on child access to tobacco in the home and home Smoking/Vaping bans among Black/African American women caregivers who smoke and live in Resource-limited, rural areas (2024)
-
TimeNorm: a novel normalization method for time course microbiome data (2024)
-
Using Concept Mapping to Identify Community Partners’ and Researchers’ Perceptions of Social Justice: A Path Toward Eliminating Chronic Disease Disparities (2024)
Grants & Funding
As listed on this researcher's institutional profile.
- FOOD AS MEDICINE: ADDRESSING SOCIAL DETERMINANTS OF HEALTH (FOOD INSECURITY) TO EFFECT CLINICAL OUTCOMES (CEAL) Westat via Westat Co-Investigator
- Center for Native American Environmental Health Equity Research NIH, EPA Other Key Personnel
- Center for Research, Health and Society NIH Co-Investigator
- Understanding Risk Gradients from Environment on Native American Child Health Trajectories: Toxicants, Immunomodulation, Metabolic syndromes, & Metals Exposure NIH/Office of the Director via University of New Mexico Principal Investigator
- UNM Metal Exposure Toxicity Assessment on Tribal Lands in the Southwest (METALS) Superfund Research Program NIH/Nat. Inst. of Environmental Health Sciences via University of New Mexico Principal Investigator
- DISCOVAR:Disparities in Immune Response to SARS-CoV-2 in ARkansas NIH Co-Investigator
- Preventing immune system dysregulation during deep-space missions by Tocofexol, a modified isomer of vitamin E - AA request National Aeronautics & Space Administration via Arkansas Space Grant Consortium Other Key Personnel
- Arkansas CASS: Arkansas Coronavirus Antibodies Seroprevalence Survey State of Arkansas Faculty
- Center for Native American Environmental Health Equity Research NIH/National Center on Minority Health and Health Disparities via University of New Mexico Principal Investigator
- Platelets in radiation-induced immune dysregulation NIH Co-Investigator
- Evaluation of the ANGELS High Risk Pregnancy Program Arkansas Department of Health and Human Services Faculty
- Community Engagement Research Alliance (CEAL) 2023-2024 Renewal NIH/Nat. Heart, Lung & Blood Institute via Westat Other Key Personnel
Collaboration Network
Top Collaborators
- Pediatric SARS-CoV-2 Seroprevalence in Arkansas Over the First Year of the COVID-19 Pandemic
- Mission, Organization, and Future Direction of the Serological Sciences Network for COVID-19 (SeroNet) Epidemiologic Cohort Studies
- Temporal Variations in Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Infections by Race and Ethnicity in Arkansas
- State-wide random seroprevalence survey of SARS-CoV-2 past infection in a southern US State, 2020
- Temporal Variations in Seroprevalence of SARS-CoV-2 Infections by Race and Ethnicity in Arkansas
Showing 5 of 6 shared publications
- Pediatric SARS-CoV-2 Seroprevalence in Arkansas Over the First Year of the COVID-19 Pandemic
- Temporal Variations in Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Infections by Race and Ethnicity in Arkansas
- State-wide random seroprevalence survey of SARS-CoV-2 past infection in a southern US State, 2020
- Temporal Variations in Seroprevalence of SARS-CoV-2 Infections by Race and Ethnicity in Arkansas
- Pediatric SARS-CoV-2 seroprevalence in Arkansas over the first year of the COVID-19 pandemic
- Pediatric SARS-CoV-2 Seroprevalence in Arkansas Over the First Year of the COVID-19 Pandemic
- Temporal Variations in Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Infections by Race and Ethnicity in Arkansas
- State-wide random seroprevalence survey of SARS-CoV-2 past infection in a southern US State, 2020
- Temporal Variations in Seroprevalence of SARS-CoV-2 Infections by Race and Ethnicity in Arkansas
- Pediatric SARS-CoV-2 seroprevalence in Arkansas over the first year of the COVID-19 pandemic
- Pediatric SARS-CoV-2 Seroprevalence in Arkansas Over the First Year of the COVID-19 Pandemic
- Temporal Variations in Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Infections by Race and Ethnicity in Arkansas
- State-wide random seroprevalence survey of SARS-CoV-2 past infection in a southern US State, 2020
- Temporal Variations in Seroprevalence of SARS-CoV-2 Infections by Race and Ethnicity in Arkansas
- Pediatric SARS-CoV-2 seroprevalence in Arkansas over the first year of the COVID-19 pandemic
- Pediatric SARS-CoV-2 Seroprevalence in Arkansas Over the First Year of the COVID-19 Pandemic
- Temporal Variations in Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Infections by Race and Ethnicity in Arkansas
- State-wide random seroprevalence survey of SARS-CoV-2 past infection in a southern US State, 2020
- Temporal Variations in Seroprevalence of SARS-CoV-2 Infections by Race and Ethnicity in Arkansas
- Pediatric SARS-CoV-2 seroprevalence in Arkansas over the first year of the COVID-19 pandemic
- Pediatric SARS-CoV-2 Seroprevalence in Arkansas Over the First Year of the COVID-19 Pandemic
- Temporal Variations in Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Infections by Race and Ethnicity in Arkansas
- State-wide random seroprevalence survey of SARS-CoV-2 past infection in a southern US State, 2020
- Temporal Variations in Seroprevalence of SARS-CoV-2 Infections by Race and Ethnicity in Arkansas
- Pediatric SARS-CoV-2 seroprevalence in Arkansas over the first year of the COVID-19 pandemic
- Pediatric SARS-CoV-2 Seroprevalence in Arkansas Over the First Year of the COVID-19 Pandemic
- Temporal Variations in Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Infections by Race and Ethnicity in Arkansas
- State-wide random seroprevalence survey of SARS-CoV-2 past infection in a southern US State, 2020
- Temporal Variations in Seroprevalence of SARS-CoV-2 Infections by Race and Ethnicity in Arkansas
- Pediatric SARS-CoV-2 seroprevalence in Arkansas over the first year of the COVID-19 pandemic
- Pediatric SARS-CoV-2 Seroprevalence in Arkansas Over the First Year of the COVID-19 Pandemic
- Temporal Variations in Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Infections by Race and Ethnicity in Arkansas
- State-wide random seroprevalence survey of SARS-CoV-2 past infection in a southern US State, 2020
- Temporal Variations in Seroprevalence of SARS-CoV-2 Infections by Race and Ethnicity in Arkansas
- Pediatric SARS-CoV-2 seroprevalence in Arkansas over the first year of the COVID-19 pandemic
- Dysregulation of the PRUNE2/PCA3 genetic axis in human prostate cancer: from experimental discovery to validation in two independent patient cohorts
- A weight Jackknife approach utilizing linear model based-estimators for clustered data
- Dysregulation of the PRUNE2/PCA3 genetic axis in human prostate cancer: From experimental discovery to validation in two independent patient cohorts
- Author response: Dysregulation of the PRUNE2/PCA3 genetic axis in human prostate cancer: from experimental discovery to validation in two independent patient cohorts
- A data-driven single substitution to overcome bias from conventional single substitution for LOD missingness in covariates in least squares regression
- Pediatric SARS-CoV-2 Seroprevalence in Arkansas Over the First Year of the COVID-19 Pandemic
- Temporal Variations in Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Infections by Race and Ethnicity in Arkansas
- Temporal Variations in Seroprevalence of SARS-CoV-2 Infections by Race and Ethnicity in Arkansas
- Contributing Factors to Delay of Adjuvant Postsurgical Radiation for Malignant Brain Tumors
- Mission, Organization, and Future Direction of the Serological Sciences Network for COVID-19 (SeroNet) Epidemiologic Cohort Studies
- Temporal Variations in Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Infections by Race and Ethnicity in Arkansas
- State-wide random seroprevalence survey of SARS-CoV-2 past infection in a southern US State, 2020
- Temporal Variations in Seroprevalence of SARS-CoV-2 Infections by Race and Ethnicity in Arkansas
- Pediatric SARS-CoV-2 Seroprevalence in Arkansas Over the First Year of the COVID-19 Pandemic
- Temporal Variations in Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Infections by Race and Ethnicity in Arkansas
- Temporal Variations in Seroprevalence of SARS-CoV-2 Infections by Race and Ethnicity in Arkansas
- Pediatric SARS-CoV-2 seroprevalence in Arkansas over the first year of the COVID-19 pandemic
- Pediatric SARS-CoV-2 Seroprevalence in Arkansas Over the First Year of the COVID-19 Pandemic
- Temporal Variations in Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Infections by Race and Ethnicity in Arkansas
- Temporal Variations in Seroprevalence of SARS-CoV-2 Infections by Race and Ethnicity in Arkansas
- Pediatric SARS-CoV-2 seroprevalence in Arkansas over the first year of the COVID-19 pandemic
- Pediatric SARS-CoV-2 Seroprevalence in Arkansas Over the First Year of the COVID-19 Pandemic
- Temporal Variations in Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Infections by Race and Ethnicity in Arkansas
- Temporal Variations in Seroprevalence of SARS-CoV-2 Infections by Race and Ethnicity in Arkansas
- Pediatric SARS-CoV-2 seroprevalence in Arkansas over the first year of the COVID-19 pandemic
- Pediatric SARS-CoV-2 Seroprevalence in Arkansas Over the First Year of the COVID-19 Pandemic
- Temporal Variations in Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Infections by Race and Ethnicity in Arkansas
- Temporal Variations in Seroprevalence of SARS-CoV-2 Infections by Race and Ethnicity in Arkansas
- Pediatric SARS-CoV-2 seroprevalence in Arkansas over the first year of the COVID-19 pandemic
Similar Researchers
Based on overlapping research topics